GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Protia (XKRX:303360) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 29, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Protia Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Protia's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Protia's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Protia's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Protia's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Protia's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Protia's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Protia  (XKRX:303360) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Protia Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Protia's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Protia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Protia Inc (XKRX:303360) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XKRX:221800 XKRX:086040 XKRX:246250 XKRX:229000 XKRX:109820 XKRX:031860 XKRX:363250 XKRX:950200 XKRX:122310 XKRX:236340 TMO DHR XSWX:LONN IDXX A SHSE:603259 IQV MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
Room 702, Building A, 401 Yangcheon-ro, Gangseo-gu, Seoul, KOR, 07528
Website
http://www.protia.co.kr
Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,' as well as various immunochemical in vitro diagnostic products.

Protia Headlines

No Headlines